Cameron Camp shares insight into why many medical professionals are concerned about approval of the drug aducanumab for the treatment of Alzheimer’s Disease in this guest post in Psychology Today.

Read more at www.psychologytoday.com/us/blog/american-dementia/202202/alzheimers-disease-and-the-elephants-in-the-room